Mechanistic Pharmacokinetic/Pharmacodynamic Modeling in Support of a Patient-Convenient, Longer Dosing Interval for Carfilzomib, a Covalent Inhibitor of the Proteasome
2023 · Clinical Pharmacokinetics · 5 citations
https://doi.org/10.1007/s40262-023-01242-6